Results of the French Multicentric Study of ANACONDA™ Fenestrated Endografts in the Treatment of Complex Aortic Pathologies (EFEFA Registry)

Midy, D.; Becquemin, Jean‐Pierre; Mialhe, Claude; Frisch, Nicolas; Martinez, Robert; Caradu, Caroline

doi:10.1016/j.avsg.2017.03.171

Cited by 20 publications

(32 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The average rate of limb occlusion was 9.0%, which is higher than most earlier studies on the Fenestrated Anaconda™ (occlusion rate 0-7.0%). 9,11,[18][19][20][21]28 Only Shahverdyan et al found an exceptionally high occlusion rate of 23%, with a plausible explanation in less than half of cases and no significant differences J o u r n a l P r e -p r o o f in limb oversizing, EIA kinking, or distal landing zone. 22 The current study showed varying occlusion rates between participating centers (0 to 22.4%).…”

Section: Discussionmentioning

confidence: 98%

“…[9][10][11][12] Despite a good overall performance, relatively high rates of limb occlusion are seen in both the infrarenal and Fenestrated Anaconda™; up to 14% and 23% respectively. 9,11,[13][14][15][16][17][18][19][20][21][22][23][24][25] The aim of this study was to describe the incidence, risk factors, and outcomes of treatment for limb occlusion, in patients treated for complex AAA with the Fenestrated Anaconda™.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Incidence and predictive factors for endograft limb patency of the fenestrated Anaconda endograft used for complex endovascular aneurysm repair

Leeuwerke

Niet

Geelkerken

et al. 2022

Journal of Vascular Surgery

View full text Add to dashboard Cite

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

show abstract

Section: Discussionmentioning

confidence: 98%

Section: Introductionmentioning

confidence: 99%

Incidence and predictive factors for endograft limb patency of the fenestrated Anaconda endograft used for complex endovascular aneurysm repair

Leeuwerke

Niet

Geelkerken

et al. 2022

Journal of Vascular Surgery

View full text Add to dashboard Cite

show abstract

“…109 Recent studies have confirmed this excellent out-come with a 0 to 7% 30-day mortality and 95 to 98% visceral vessel patency. [110][111][112] On the contrary, the 30-day mortality and target vessel patency were 1 to 4% and 92 to 96%, respectively, with the snorkel EVAR. [113][114][115]…”

Section: Infrarenal Abdominal Aortic Aneurysmmentioning

confidence: 98%

Endovascular Treatment of Various Aortic Pathologies: Review of the Latest Data and Technologies

2018

View full text Add to dashboard Cite

The technologies and innovations applicable to endovascular treatment for complex aortic pathologies have progressed rapidly over the last two decades. Although the initial outcomes of an endovascular aortic repair have been excellent, as long-term data became available, complications including endoleaks, endograft migration, and endograft infection have become apparent and are of concern. Previously, the indication for endovascular therapy was restricted to descending thoracic aortic aneurysms and abdominal aortic aneurysms. However, its indication has expanded along with the improvement of techniques and devices, and currently, it has become possible to treat pararenal aortic aneurysms and Crawford type 4 thoracoabdominal aortic aneurysm (TAAA) using the off-the-shelf devices. Additionally, custom-made devices allow for the treatment of arch or more extensive TAAAs. Endovascular treatment is applied not only to aneurysms but also to acute/chronic dissections. However, long-term outcomes are still unclear. This article provides an overview of available devices and the results of endovascular treatment for various aortic pathologies.

show abstract

“…It has been demonstrated that FEVAR is a feasible treatment modality across multiple centres in large registries 2 , 3 as well as in several cases reporting mid-term follow-up. 4 , 5 However, the concern of endovascular aneurysm repair has always been long-term durability and FEVAR is no exception.…”

Section: Introductionmentioning

confidence: 99%

Characterising the incidence and mode of visceral stent failure after fenestrated endovascular aneurysm repair (FEVAR)

Patel

Roy

McWilliams

et al. 2021

JRSM Cardiovascular Disease

View full text Add to dashboard Cite

Background In FEVAR, visceral stents provide continuity and maintain perfusion between the main body of the stent and the respective visceral artery. The aim of this study was to characterise the incidence and mode of visceral stent failure (type Ic endoleak, type IIIa endoleak, stenosis/kink, fracture, crush and occlusion) after FEVAR in a large cohort of patients at a high-volume centre. Methods A retrospective review of visceral stents placed during FEVAR over 15 years (February 2003-December 2018) was performed. Kaplan-Meier analyses of freedom from visceral stent-related complications were performed. The outcomes between graft configurations of varying complexity were compared, as were the outcomes of different stent types and different visceral vessels. Results Visceral stent complications occurred in 47/236 patients (19.9%) and 54/653 stents (8.3%). Median follow up was 3.7 years (IQR 1.7–5.3 years). There was no difference in visceral stent complication rate between renal, SMA and coeliac arteries. Visceral stent complications were more frequent in more complex grafts compared to less complex grafts. Visceral stent complications were more frequent in uncovered stents compared to covered stents. Visceral stent-related endoleaks (type Ic and type IIIa) occurred exclusively around renal artery stents. The most common modes of failure with SMA stents were kinking and fracture, whereas with coeliac artery stents it was external crush. Conclusion Visceral stent complications after FEVAR are common and merit continued and close long-term surveillance. The mode of visceral stent failure varies across the vessels in which the stents are located.

show abstract

Results of the French Multicentric Study of ANACONDA™ Fenestrated Endografts in the Treatment of Complex Aortic Pathologies (EFEFA Registry)

Cited by 20 publications

References 37 publications

Incidence and predictive factors for endograft limb patency of the fenestrated Anaconda endograft used for complex endovascular aneurysm repair

Incidence and predictive factors for endograft limb patency of the fenestrated Anaconda endograft used for complex endovascular aneurysm repair

Endovascular Treatment of Various Aortic Pathologies: Review of the Latest Data and Technologies

Characterising the incidence and mode of visceral stent failure after fenestrated endovascular aneurysm repair (FEVAR)

Contact Info

Product

Resources

About